Convergent perturbation of the human domain-resolved interactome by viruses and mutations inducing similar disease phenotypes

PLoS Computational Biology

Volumn 15, Issue 2, 2019, Pages

  Chen, Yangchun Frank ^a   Xia, Yu ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS; VIRUSES;

DISEASE PHENOTYPES; ENVIRONMENTAL PERTURBATIONS; GENETIC MUTATIONS; HIGH RESOLUTION; HUMAN DOMAIN; INTERACTOME; INTERACTOME NETWORKS; ONCOPROTEINS; PROTEIN DOMAINS; VIRAL PROTEINS;

DISEASES;

ONCOPROTEIN; PROTEIN; VIRAL PROTEIN;

ARTICLE; DISEASES; GENE MUTATION; MALIGNANT NEOPLASM; PHENOTYPE; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; TUMOR VIRUS; VIRUS; BIOLOGY; CHEMISTRY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MUTATION; PROCEDURES; PROTEIN ANALYSIS; VIRUS INFECTION;

COMPUTATIONAL BIOLOGY; HOST-PATHOGEN INTERACTIONS; HUMANS; MUTATION; PHENOTYPE; PROTEIN DOMAINS; PROTEIN INTERACTION MAPS; PROTEINS; VIRAL PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 85061618523     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1006762     Document Type: Article

References (88)

1. Vidal M., Cusick M.E., and Barabasi A.L., Interactome networks and human disease. Cell, 2011. 144 (6): p. 986–98. https://doi.org/10.1016/j.cell.2011.02.016 PMID: 21414488
2. Oliver S., Guilt-by-association goes global. Nature, 2000. 403(6770): p. 601–3. https://doi.org/10.1038/35001165 PMID: 10688178
3. Barabasi A.L., Network medicine—from obesity to the "diseasome". N Engl J Med, 2007. 357(4): p. 404–7. https://doi.org/10.1056/NEJMe078114 PMID: 17652657
4. Goh K.I., et al., The human disease network. Proc Natl Acad Sci U S A, 2007. 104(21): p. 8685–90. https://doi.org/10.1073/pnas.0701361104 PMID: 17502601
5. Zhong Q., et al., Edgetic perturbation models of human inherited disorders. Mol Syst Biol, 2009. 5: p. 321. https://doi.org/10.1038/msb.2009.80 PMID: 19888216
6. Wang X., et al., Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol, 2012. 30(2): p. 159–64. https://doi.org/10.1038/nbt.2106 PMID: 22252508
7. Sahni N., et al., Edgotype: a fundamental link between genotype and phenotype. Curr Opin Genet Dev, 2013. 23(6): p. 649–57. https://doi.org/10.1016/j.gde.2013.11.002 PMID: 24287335
8. Sahni N., et al., Widespread macromolecular interaction perturbations in human genetic disorders. Cell, 2015. 161(3): p. 647–60. https://doi.org/10.1016/j.cell.2015.04.013 PMID: 25910212
9. Gulbahce N., et al., Viral perturbations of host networks reflect disease etiology. PLoS Comput Biol, 2012. 8(6): p. e1002531. https://doi.org/10.1371/journal.pcbi.1002531 PMID: 22761553
10. Rozenblatt-Rosen O., et al., Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature, 2012. 487(7408): p. 491–5. https://doi.org/10.1038/nature11288 PMID: 22810586
11. Kim P.M., et al., Relating three-dimensional structures to protein networks provides evolutionary insights. Science, 2006. 314(5807): p. 1938–41. https://doi.org/10.1126/science.1136174 PMID: 17185604
12. Franzosa E.A. and Xia Y., Structural principles within the human-virus protein-protein interaction network. Proc Natl Acad Sci U S A, 2011. 108(26): p. 10538–43. https://doi.org/10.1073/pnas. 1101440108 PMID: 21680884
13. Garamszegi S., Franzosa E.A., and Xia Y., Signatures of pleiotropy, economy and convergent evolution in a domain-resolved map of human-virus protein-protein interaction networks. PLoS Pathog, 2013. 9 (12): p. e1003778. https://doi.org/10.1371/journal.ppat.1003778 PMID: 24339775
14. Orchard S., et al., The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res, 2014. 42(Database issue): p. D358–63. https://doi.org/10.1093/nar/gkt1115 PMID: 24234451
15. Ammari M.G., et al., HPIDB 2.0: a curated database for host-pathogen interactions. Database (Oxford), 2016. 2016.
16. Fu W., et al., Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res, 2009. 37(Database issue): p. D417–22. https://doi.org/10.1093/nar/gkn708PMID: 18927109
17. Ptak R.G., et al., Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retrovi-ruses, 2008. 24(12): p. 1497–502. https://doi.org/10.1089/aid.2008.0113 PMID: 19025396
18. Pinney J.W., et al., HIV-host interactions: a map of viral perturbation of the host system. AIDS, 2009. 23(5): p. 549–54. https://doi.org/10.1097/QAD.0b013e328325a495 PMID: 19262354
19. Mosca R., et al., 3did: a catalog of domain-based interactions of known three-dimensional structure. Nucleic Acids Res, 2014. 42(Database issue): p. D374–9. https://doi.org/10.1093/nar/gkt887 PMID: 24081580
20. Dinkel H., et al., ELM 2016—data update and new functionality of the eukaryotic linear motif resource. Nucleic Acids Res, 2016. 44(D1): p. D294–300. https://doi.org/10.1093/nar/gkv1291 PMID: 26615199
21. Finn R.D., et al., iPfam: a database of protein family and domain interactions found in the Protein Data Bank. Nucleic Acids Res, 2014. 42(Database issue): p. D364–73. https://doi.org/10.1093/nar/gkt1210 PMID: 24297255
22. Berman H.M., et al., The Protein Data Bank. Nucleic Acids Res, 2000. 28(1): p. 235–42. PMID: 10592235
23. Finn R.D., et al., The Pfam protein families database: towards a more sustainable future. Nucleic Acids Res, 2016. 44(D1): p. D279–85. https://doi.org/10.1093/nar/gkv1344 PMID: 26673716
24. Famiglietti M.L., et al., Genetic variations and diseases in UniProtKB/Swiss-Prot: the ins and outs of expert manual curation. Hum Mutat, 2014. 35(8): p. 927–35. https://doi.org/10.1002/humu.22594 PMID: 24848695
25. Landrum M.J., et al., ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res, 2016. 44(D1): p. D862–8. https://doi.org/10.1093/nar/gkv1222 PMID: 26582918
26. Hanahan D. and Weinberg R.A., The hallmarks of cancer. Cell, 2000. 100(1): p. 57–70. PMID: 10647931
27. Mesri E.A., Feitelson M.A., and Munger K., Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe, 2014. 15(3): p. 266–82. https://doi.org/10.1016/j.chom.2014.02.011 PMID: 24629334
28. Epstein M.A., Achong B.G., and Barr Y.M., Virus Particles in Cultured Lymphoblasts from Burkitt’s Lymphoma. Lancet, 1964. 1(7335): p. 702–3. PMID: 14107961
29. Wang S., et al., Identification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing Technology. Sci Rep, 2016. 6: p. 26156. https://doi. org/10.1038/srep26156 PMID: 27189712
30. Kimura H., et al., EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood, 2012. 119(3): p. 673–86. https://doi.org/10.1182/blood-2011-10-381921 PMID: 22096243
31. Lung M.L., et al., The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma. Chin J Cancer, 2014. 33(11): p. 556–68. https://doi.org/10.5732/cjc.014. 10170 PMID: 25367335
32. Fukayama M., Hino R., and Uozaki H., Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci, 2008. 99(9): p. 1726–33. https://doi.org/10.1111/j.1349-7006.2008. 00888.x PMID: 18616681
33. Schiffman M., et al., Human papillomavirus and cervical cancer. Lancet, 2007. 370(9590): p. 890–907. https://doi.org/10.1016/S0140-6736(07)61416-0 PMID: 17826171
34. Nulton T.J., et al., Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma. Oncotarget, 2017. 8 (11): p. 17684–17699. https://doi.org/10.18632/oncotarget.15179 PMID: 28187443
35. Moscicki A.B., et al., Updating the natural history of human papillomavirus and anogenital cancers. Vaccine, 2012. 30 Suppl 5: p. F24–33.
36. Li N., et al., Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis, 2011. 204(2): p. 217–23. https://doi.org/10.1093/infdis/jir248 PMID: 21673031
37. Li N., et al., Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat, 2011. 126(2): p. 515–20. https://doi.org/10.1007/s10549-010-1128-0 PMID: 20740311
38. Klein F., Amin Kotb W.F., and Petersen I., Incidence of human papilloma virus in lung cancer. Lung Cancer, 2009. 65(1): p. 13–8. https://doi.org/10.1016/j.lungcan.2008.10.003PMID: 19019488
39. Singh N., et al., Implication of high risk human papillomavirus HR-HPV infection in prostate cancer in Indian population—a pioneering case-control analysis. Sci Rep, 2015. 5: p. 7822. https://doi.org/10. 1038/srep07822 PMID: 25592643
40. Monforte A., et al., HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS, 2008. 22(16): p. 2143–53. https://doi.org/10.1097/QAD. 0b013e3283112b77 PMID: 18832878
41. Grulich A.E., et al., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet, 2007. 370(9581): p. 59–67.https://doi.org/10.1016/S0140-6736(07)61050-2 PMID: 17617273
42. De Falco G., et al., Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene, 2003. 22(40): p. 6214–9. https://doi.org/10.1038/sj.onc.1206637 PMID: 13679860
43. Nunnari G., Smith J.A., and Daniel R., HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? J Exp Clin Cancer Res, 2008. 27: p. 3. https://doi.org/10.1186/1756-9966-27-3 PMID: 18577246
44. Briggs S.D., et al., SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J Biol Chem, 1997. 272(29): p. 17899–902. PMID: 9218412
45. Barbaro G., Cardiovascular manifestations of HIV infection. Circulation, 2002. 106(11): p. 1420–5. PMID: 12221062
46. Pugliese A., et al., Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect, 2000. 40(3): p. 282–4. https://doi.org/10.1053/jinf.2000.0672 PMID: 10908024
47. Yunis N.A. and Stone V.E., Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. J Acquir Immune Defic Syndr Hum Retrovirol, 1998. 18(2): p. 145–54. PMID: 9637579
48. Hersh B.P., Rajendran P.R., and Battinelli D., Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART. Neurology, 2001. 56(2): p. 278–9. PMID: 11160977
49. Koutsilieri E., et al., Parkinsonism in HIV dementia. J Neural Transm (Vienna), 2002. 109(5–6): p. 767– 75.
50. Mirsattari S.M., Power C., and Nath A., Parkinsonism with HIV infection. Mov Disord, 1998. 13(4): p. 684–9. https://doi.org/10.1002/mds.870130413 PMID: 9686775
51. Kumar A., et al., Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Sci Rep, 2016. 6: p. 24090. https://doi.org/10.1038/srep24090 PMID: 27076174
52. Portis T., Dyck P., and Longnecker R.,Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood, 2003. 102(12): p. 4166–78. https://doi.org/10.1182/blood-2003-04-1018 PMID: 12907455
53. Lamers S.L., et al., HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol, 2012. 31(6): p. 432–50. https://doi.org/10.3109/08830185.2012.737073 PMID: 23215766
54. Plummer M., et al., Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health, 2016. 4(9): p. e609–16. https://doi.org/10.1016/S2214-109X(16)30143-7 PMID: 27470177
55. Vogt P.K., Retroviral oncogenes: a historical primer. Nat Rev Cancer, 2012. 12(9): p. 639–48. https://doi.org/10.1038/nrc3320 PMID: 22898541
56. Stevenson P.G., Simas J.P., and Efstathiou S., Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4. J Gen Virol, 2009. 90(Pt 10): p. 2317–30. https://doi.org/10.1099/vir. 0.013300-0 PMID: 19605591
57. Parada L.F., et al., Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature, 1982. 297(5866): p. 474–8. PMID: 6283357
58. de Martel C., et al., Cancers attributable to infections among adults with HIV in the United States. AIDS, 2015. 29(16): p. 2173–81. https://doi.org/10.1097/QAD.0000000000000808 PMID: 26182198
59. Manabe A., et al., Viral Infections in Juvenile Myelomonocytic Leukemia: Prevalence and Clinical Implications. J Pediatr Hematol Oncol, 2004. 26(10): p. 636–641.
60. Koike K. and Matsuda K., Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol, 2008. 141(5): p. 567–75. https://doi.org/10.1111/j.1365-2141.2008. 07104.x PMID: 18422786
61. Kaplan M., et al., EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMR. Cell, 2016. 167(5): p. 1241–1251 e11. https://doi.org/10.1016/j.cell.2016.10.038 PMID: 27839865
62. Purba E.R., Saita E.I., and Maruyama I.N., Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model". Cells, 2017. 6(2).
63. Glocker E.O., et al., Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med, 2009. 361(21): p. 2033–45. https://doi.org/10.1056/NEJMoa0907206 PMID: 19890111
64. Slobedman B., et al., Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol, 2009. 83(19): p. 9618–29. https://doi.org/10.1128/JVI.01098-09 PMID: 19640997
65. DeBruyne L.A., et al., Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther, 1998. 5(8): p. 1079–87. https://doi.org/10.1038/sj.gt.3300694 PMID: 10326031
66. Beguelin W., et al., IL10 receptor is a novel therapeutic target in DLBCLs. Leukemia, 2015. 29(8): p. 1684–94. https://doi.org/10.1038/leu.2015.57 PMID: 25733167
67. Pietrek M., et al., Role of the Kaposi’s sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation. J Virol, 2010. 84(16): p. 8231–40. https://doi.org/10.1128/JVI. 01696-09 PMID: 20534855
68. Myoui A., et al., C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res, 2003. 63(16): p. 5028–33. PMID: 12941830
69. Imielinski M., et al., Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell, 2012. 150(6): p. 1107–20. https://doi.org/10.1016/j.cell.2012.08.029 PMID: 22980975
70. Campbell K.S., et al., Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc Natl Acad Sci U S A, 1994. 91(14): p. 6344–8. PMID: 8022784
71. Ahn R., et al., The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression. Cancer Res, 2013. 73(14): p. 4521–32. https://doi.org/10.1158/0008-5472.CAN-12-4178 PMID: 23695548
72. Dussupt V., et al., The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog, 2009. 5(3): p. e1000339. https://doi.org/10.1371/journal.ppat.1000339 PMID: 19282983
73. Castiglioni S., Maier J.A., and Mariotti M., The tyrosine phosphatase HD-PTP: A novel player in endothelial migration. Biochem Biophys Res Commun, 2007. 364(3): p. 534–9. https://doi.org/10.1016/j. bbrc.2007.10.022 PMID: 17959146
74. Manteghi S., et al., Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer. Cell Rep, 2016. 15(9): p. 1893–900. https://doi.org/10.1016/j.celrep.2016.04.076 PMID: 27210750
75. Stratton M.R., Campbell P.J., and Futreal P.A., The cancer genome. Nature, 2009. 458(7239): p. 719– 24. https://doi.org/10.1038/nature07943 PMID: 19360079
76. Forbes S.A., et al., COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res, 2017. 45 (D1): p. D777–D783. https://doi.org/10.1093/nar/gkw1121 PMID: 27899578
77. Aloy P. and Russell R.B., Structural systems biology: modelling protein interactions. Nat Rev Mol Cell Biol, 2006. 7(3): p. 188–97. https://doi.org/10.1038/nrm1859 PMID: 16496021
78. Haddad L., et al., KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells. Leukemia, 2008. 22(4): p. 826–34. https://doi.org/10.1038/sj.leu.2405081 PMID: 18094712
79. Keller S.A., et al., NF-kappaB is essential for the progression of KSHV-and EBV-infected lymphomas in vivo. Blood, 2006. 107(8): p. 3295–302. https://doi.org/10.1182/blood-2005-07-2730 PMID: 16380446
80. Mort M., et al., A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat, 2008. 29(8): p. 1037–47. https://doi.org/10.1002/humu.20763 PMID: 18454449
81. Jones P., et al., InterProScan 5: genome-scale protein function classification. Bioinformatics, 2014. 30 (9): p. 1236–40. https://doi.org/10.1093/bioinformatics/btu031 PMID: 24451626
82. McLaren W., et al., The Ensembl Variant Effect Predictor. Genome Biol, 2016. 17(1): p. 122. https://doi.org/10.1186/s13059-016-0974-4PMID: 27268795
83. Kibbe W.A., et al., Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Res, 2015. 43(Database issue): p. D1071–8. https://doi.org/10.1093/nar/gku1011 PMID: 25348409
84. Rath A., et al., Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Hum Mutat, 2012. 33(5): p. 803–8. https://doi.org/10.1002/humu. 22078 PMID: 22422702
85. Team, R.C., R: A language and environment for statistical computing. 2018, R Foundation for Statistical Computing: Vienna, Austria.
86. Omasits U., et al., Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics, 2014. 30(6): p. 884–6. https://doi.org/10.1093/bioinformatics/btt607 PMID: 24162465
87. Finn R.D., et al., InterPro in 2017-beyond protein family and domain annotations. Nucleic Acids Res, 2017. 45(D1): p. D190–D199. https://doi.org/10.1093/nar/gkw1107 PMID: 27899635
88. Phipson B. and Smyth G.K., Permutation P-values should never be zero: calculating exact P-values when permutations are randomly drawn. Stat Appl Genet Mol Biol, 2010. 9: p. Article 39.